Bibliography

Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R [S] T U V W X Y Z   [Show ALL]
3,4-Dihydroxyphenylacetic Acid
Tedford CE, Schott MJ, Flynn JR, Cannon JG, Long JP. A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Absorptiometry, Photon
Smith CS, Hailey D, Drummond M. The role of economic appraisal in health technology assessment: the Australian case. Soc Sci Med. 1994;38(12):1653-62. Abstract
Abstracting and Indexing
Li L, Smith HE, Atun R, Tudor Car L. Search strategies to identify observational studies in MEDLINE and Embase. Cochrane Database Syst Rev. 2019;3:MR000041. Abstract
Abstracting and Indexing as Topic
Sampson M, Zhang L, Morrison A, Barrowman NJ, Clifford TJ, Platt RW, et al. An alternative to the hand searching gold standard: validating methodological search filters using relative recall. BMC Med Res Methodol. 2006;6:33. Abstract
Linder SK, Kamath GR, Pratt GF, Saraykar SS, Volk RJ. Citation searches are more sensitive than keyword searches to identify studies using specific measurement instruments. J Clin Epidemiol. 2015;68(4):412-7. Abstract
Hopewell S, Clarke M, Lefebvre C, Scherer R. Handsearching versus electronic searching to identify reports of randomized trials. Cochrane Database Syst Rev. 2007;(2):MR000001. Abstract
Academies and Institutes
Fernandez AM, Schrogie JJ, Wilson WW, Nash DB. Technology assessment in healthcare: a review and description of a "best practice" technology assessment process. Best Pract Benchmarking Healthc. 1997;2(6):240-53. Abstract
Acetylcholine
Tedford CE, Schott MJ, Flynn JR, Cannon JG, Long JP. A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Adolescent
Bombard Y, Abelson J, Simeonov D, Gauvin F-. Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med. 2011;73(1):135-44. Abstract
Shenderovich Y, Eisner M, Mikton C, Gardner F, Liu J, Murray J. Methods for conducting systematic reviews of risk factors in low- and middle-income countries. BMC Med Res Methodol. 2016;16:32. Abstract
Sullivan SM, Tsiplova K, Ungar WJ. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Lauslahti K, Roine R, Semberg V, Kekomäki M, Konttinen M, Karp P. Health technology assessment in Finland. Int J Technol Assess Health Care. 2000;16(2):382-99. Abstract
Bombard Y, Abelson J, Simeonov D, Gauvin F-. Citizens' perspectives on personalized medicine: a qualitative public deliberation study. Eur J Hum Genet. 2013;21(11):1197-201. Abstract
Adult
Jonsson E, Banta HD, Schersten T. Health technology assessment and screening in Sweden. Int J Technol Assess Health Care. 2001;17(3):380-8. Abstract
Faisst K, Schilling J, Koch P. Health technology assessment of three screening methods in Switzerland. Int J Technol Assess Health Care. 2001;17(3):389-99. Abstract
Basch E, Abernethy AP, Mullins DC, Reeve BB, Smith ML, Coons SJ, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol. 2012;30(34):4249-55. Abstract
Bombard Y, Abelson J, Simeonov D, Gauvin F-. Citizens' perspectives on personalized medicine: a qualitative public deliberation study. Eur J Hum Genet. 2013;21(11):1197-201. Abstract
Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5. Abstract
Böckerman P, Johansson E, Saarni SI. Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being? Health Policy. 2011;100(1):91-5. Abstract
Gagnon M-, Gagnon J, St-Pierre M, Gauvin F-, Piron F, Rhainds M, et al. Involving patients in HTA activities at local level: a study protocol based on the collaboration between researchers and knowledge users. BMC Health Serv Res. 2012;12:14. Abstract
Bombard Y, Abelson J, Simeonov D, Gauvin F-. Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med. 2011;73(1):135-44. Abstract
Adverse Drug Reaction Reporting Systems
Banerjee AK, Okun S, Edwards RI, Wicks P, Smith MY, Mayall SJ, et al. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance. Drug Saf. 2013;36(12):1129-49. Abstract
Pietanza CM, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, et al. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract
Advisory Committees
Abelson J, Bombard Y, Gauvin F-, Simeonov D, Boesveld S. Assessing the impacts of citizen deliberations on the health technology process. Int J Technol Assess Health Care. 2013;29(3):282-9. Abstract
Age Factors
Sullivan SM, Tsiplova K, Ungar WJ. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract